Davis, Emily. 2025. “Efficacy of Targeted MRNA Therapeutics in Refractory Autoimmune Disorders: A Phase II Clinical Trial”. Medicine Insights 2 (4): 36-47. https://doi.org/10.70088/ba518d61.